Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Blundell J, Finlayson G, Axelsen M, et al. Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.

The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

While people lost more weight on tirzepatide than semaglutide, it’s still a significant amount of weight, since research considers effective weight loss of more than 5% of body weight after 12 ...

“This may be more prominent with semaglutide, as it is known to decrease weight more rapidly than bupropion-naltrexone, thus inducing greater physiological stress on the body and thus potentiall ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that ... able to shed more than a fifth of their body weight. The phase 3b STEP UP trial in more ...

A 2021 study found that, on average, people lost more than 2% of their body weight in the first 4 weeks of using semaglutide. (Semaglutide is the active ingredient in Wegovy.) For example ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP ... Baseline characteristics showed that patients had a lower body mass index (BMI) (median, 28 kg/m 2) than in other trials of GLP-1 agonists ...